We found that the plasma levels of HP, LTA4H, S100A9, SAA1, SAA2, and SERPINA3 were significantly elevated in more severe COVID-19 conditions (Figures 7A–F), exhibiting good clinical predictive value and promising applications. This evidence concerns the gene HP and COVID-19.